NEW YORK (GenomeWeb News) – Agilent Technologies today said that it will collaborate with sera prognostics on the development of proteomic assays for early prediction of pregnancy complications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.